Alto Neuroscience, Inc.
Develops precision medicines for neuropsychiatric conditions using patient biology.
ANRO | US
Overview
Corporate Details
- ISIN(s):
- US02157Q1094
- LEI:
- Country:
- United States of America
- Address:
- 650 CASTRO STREET, SUITE 450, 94041 MOUNTAIN VIEW
- Sector:
- Manufacturing
Description
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for neuropsychiatric conditions. The company's approach utilizes its Precision Psychiatry Platform, which leverages neurobiological data such as EEG and cognitive assessments to identify patient subpopulations most likely to respond to its targeted drug candidates. This biology-driven method aims to move beyond the traditional trial-and-error approach in mental health treatment by predicting clinical response. Alto's clinical-stage pipeline includes novel drug candidates designed to address core brain processes in conditions such as major depressive disorder, bipolar depression, and schizophrenia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Alto Neuroscience, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alto Neuroscience, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alto Neuroscience, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
